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Abstract
We have recently shown that the minor capsid protein L2 of human papillomavirus type 33 (HPV33) recruits the transcriptional repressor
Daxx into nuclear domains (ND) 10 and causes the loss of the transcriptional activator Sp100 from these subnuclear structures (Florin et
al., 2002b). In order to dissect L2 domains involved in nuclear translocation, ND10 homing, loss of Sp100, and recruitment of Daxx, a
detailed deletion mutagenesis of L2 was performed. Using immunofluorescence and green fluorescent protein fusions, we have identified
two nuclear localization signals (NLS) in the central and C-terminal part of L2, respectively, homologous to previously identified NLS in
HPV6B L2 (Sun et al., 1995). We mapped the ND10 localization domain to within a 30 amino acid peptide in the C-terminal half of L2.
L2-induced attraction of Daxx into ND10, coimmunoprecipitation of L2 and Daxx, as well as induction of the loss of Sp100 from ND10
require an intact ND10 localization domain. This domain contains conserved PXXP motives characteristic of some protein/protein
interacting domains. Our data also suggest that the Daxx/L2 interaction may be the driving force for L2 accumulation in ND10.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Nuclear domains (ND) 10 are distinct subnuclear struc-
tures, which have been implicated in transcriptional regula-
tion, growth suppression, and apoptosis (Doucas, 2000; Li
and Chen, 2000; Li et al., 2000a; Gottifredi and Prives,
2001; Quignon et al., 1998; Torii et al., 1999; Wang et al.,
1998; Zhong et al., 2000b). They have also been proposed
to serve as transient deposition sites for nuclear factors.
Promyelocytic leukemia (PML) protein is the main struc-
tural component of ND10 (Ishov et al., 1999; Zhong et al.,
2000a), which was initially identified as fusion partner of
the retinoic acid receptor -oncogenic fusion protein in
patients with acute promyelocytic leukemia (de The et al.,
1990; Goddard et al., 1991; Kakizuka et al., 1991). Another
major component of ND10 is Sp100, which has been shown
to influence transcription and chromatin dynamics (Seeler et
al., 1998, 2001). Additional proteins have been found tran-
siently or permanently associated with these structures.
These include SUMO-1, which can modify PML and Sp100
through covalent modification (Seeler et al., 2001; Zhong et
al., 2000a), Daxx, which is involved in apoptosis and tran-
scriptional repression (Li et al., 2000a, 2000b; Torii et al.,
1999; Zhong et al., 2000b), and tumor suppressors like p53
(Gottifredi and Prives, 2001; Lain et al., 1999).
Specific regulatory early proteins of many large DNA
viruses are targeted to ND10 inducing their destruction
and/or complete reorganization. These include IE1 protein
of cytomegalovirus (Korioth et al., 1996; Ahn et al., 1998),
ICP0 protein of herpes simplex virus (Everett and Maul,
1994; Parkinson and Everett, 2000), and BZLF1 protein of
Epstein-Barr virus (Adamson and Kenney, 2001). They
interfere with the SUMO-1 modification of PML and/or
Sp100, resulting in the complete disruption of ND10.
Sometimes, PML is recruited into viral replication com-
partments later in the infection cycle (Burkham et al.,
2001).
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In contrast to large DNA viruses, small DNA tumor
viruses seem to utilize these nuclear sites for their replica-
tion without obvious reorganization. It was reported that
SV40 DNA replicates in or near ND10 (Ishov and Maul,
1996; Tang et al., 2000). Using transient replication assays,
it was also demonstrated that plasmids, carrying the repli-
cation origin of human papillomavirus type 11 (HPV11),
mainly localized close to ND10, when the viral proteins E1
and E2 were expressed in trans (Swindle et al., 1999).
Recent data suggest that ND10 are not only the sites of
HPV-DNA replication, but may also serve as sites of virus
morphogenesis. The minor capsid protein L2 of HPV-16
and -33 and of bovine papillomavirus type 1 accumulates in
these nuclear bodies (Day et al., 1998; Florin et al., 2002b;
Go¨rnemann et al., 2002). The major capsid protein L1 is
attracted into ND10 by L2 rather then being diffusely dis-
tributed in the nucleoplasm (Day et al., 1998; Florin et al.,
2002b). Surprisingly, HPV-33 L2 accumulation in ND10
results in the reorganization of these domains (Florin et al.,
2002b). Sp100 is lost and the transcriptional repressor Daxx
is recruited into these sites. In contrast, an obvious change
of PML was not observed in the presence of L2. Further-
more, L2 protein transiently colocalizes with Sp100-posi-
tive nuclear dots in HPV-infected lesions, suggesting that
ND10 are indeed involved in virus morphogenesis. To fur-
ther our understanding of the L2-induced reorganization of
ND10 and in order to dissect L2 domains involved in
nuclear translocation, ND10 homing, loss of Sp100, and
recruitment of Daxx, we have now performed a detailed
deletion mutagenesis of L2 encoded by HPV-33.
Results
A 30-amino acid peptide in addition to nuclear
localization signals determines the subcellular
localization of L2
N- and C-terminal deletion mutants of HPV33 L2 were
constructed by PCR and expressed in the human osteosar-
coma cell line HuTK using recombinant vaccinia viruses.
The mutants are schematically depicted in Fig. 1A and their
expression was demonstrated by Western blot (Fig. 1B). All
mutant proteins displayed the expected migration in SDS-
PAGE. For unknown reason, we reproducibly observe a
lower steady state level of all mutant L2 proteins compared
to wild-type (wt) L2. Subcellular localization of the mutant
proteins was analyzed using immunofluorescence (Fig. 2A).
All C-terminally deleted mutant proteins up to amino acids
(aa) 330 (L2-1/330) still localized to the nucleus. In con-
trast, L2-1/300 was not actively translocated into the nu-
cleus and was therefore mainly found in the cytoplasm. This
is indicative of a nuclear localization signal (NLS) centered
at amino acid position 300. The sequence is enriched for
arginine without the characteristics of a classical NLS (Fig.
1A). The N-terminal deletion mutant L2-360/467, compris-
ing only the C-terminal 108 amino acids, was also exclu-
sively detected in the nucleus, suggesting the presence of a
second NLS close to the C-terminus of L2 (Fig. 2A). A
characteristic feature of this polypeptide is a stretch of six
basic amino acids at position 450 to 455. This sequence is
sufficient for nuclear translocation when fused to green
fluorescent protein (GFP) (data not shown) suggesting that
it functions indeed as NLS.
Whereas the N-terminal deletion mutant L2-360/467 and
the C-terminal mutant L2-1/420 were both found in the
punctate nuclear pattern characteristic of wtL2 (Fig. 2A),
removal of the C-terminal 77 amino acids (L2-12/390) or
more (L2-1/360 and -1/330) resulted in a diffuse nucleo-
plasmic staining pattern (Fig. 2A). Confocal microscopy
Fig. 1. (A) Schematical drawing of L2 mutants. Numbers on the left
indicate the L2 amino acids still present in the construct. Amino acid
sequences of the identified domains are given. NLS: nuclear localization
signal; NDLD: ND10 localization domain. (B) Expression of the L2 mu-
tants in HuTK cells using recombinant vaccinia viruses. L2 proteins were
detected by Western blot using mAb 33L2-1, which binds to L2 amino
acids 163 to 170 (Volpers et al., 1995).
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demonstrated complete colocalization with PML of L2 mu-
tants in the punctate pattern, indicative of ND10 localization
(Fig. 2B). These data suggest that the sequence extending
from aa 360 to aa 420 may be required for ND10 localiza-
tion. The ND10 localization domain (NDLD) was further
characterized using GFP-L2 fusion proteins. In agreement
with the data obtained with the L2 deletion mutants, GFP-
L2-360/467, -390/467, and -360/420, but not GFP-L2-390/
420, accumulated in ND10. GFP-L2-360/420 and -390/420
do not comprise a NLS and reach the nucleus by passive
diffusion. Therefore, cytoplasmic aggregates, which are
commonly observed for over-expressed GFP fusion pro-
teins, were found in addition (Fig. 2C). Our data indicate
that L2 amino acids 390 to 420 form the core of the NDLD.
As fusion with GFP, some adjacent L2 sequences at either
end seem to be required for ND10 localization.
The NDLD of L2 is required for loss of Sp100
We have previously shown that wt L2 protein induces
the dispersal of Sp100 from ND10 (Florin et al., 2002b). To
test if this correlates with the presence of NDLD in L2, the
effect of L2 mutant proteins on Sp100 was analyzed by
immunofluorescence. L2 mutant proteins not localizing to
ND10 (e.g. L2-1/360) had no detectable effect on Sp100
(Fig. 3). In contrast, L2 mutant proteins accumulating in
ND10, like L2-1/456, -1/420, and -150/467 also affected
Sp100 as indicated by our inability to detect this protein in
ND10 (Fig. 3). So far, our data suggest that ND10 localiza-
tion is essential for inducing the loss of Sp100.
NDLD of L2 is essential for recruitment of Daxx into
ND10
We next analyzed L2 mutant proteins for their ability to
interact with Daxx using immunofluorescence. As shown in
Fig. 4A, wtL2, L2-150/467, -1/456, and -1/420 induced the
redistribution of Daxx from the nucleoplasma into ND10.
L2 mutants localizing to the nucleoplasm, as shown for
L2-1/360 (Fig. 4A), or cytoplasm, like L2-1/300 (data not
shown), had no detectable effect on Daxx. This also dem-
onstrates that the use of recombinant vaccinia viruses alone
does not induce the ND10 reorganization. We conclude that
L2 mutant proteins, accumulating in ND10, also attract
Daxx into these nuclear structures.
Immunoprecipitation analysis was used to confirm the
interaction of Daxx with L2 mutant proteins. Whole cell
extracts prepared from HuTK cells expressing L2 mutants
were subjected to immunoprecipitation using L2-specific
monoclonal antibodies attached to magnetic beads. Lysates
and bound proteins were analyzed by Western blotting. All
extracts contained L2 proteins and similar amounts of Daxx
(Fig. 4B). With the exception of L2-1/300, which was
weakly expressed, all L2 mutant proteins were also detected
in the precipitates. Whereas Daxx coimmunoprecipitated
with wtL2, L2-1/420, and -150/467, neither L2-12/390 nor
-1/330 precipitated Daxx (Fig. 4B). Taken together with the
immunofluorescence analysis, we can conclude that L2
amino acids 390 to 420 are essential for Daxx interaction.
Our data suggest that the capacity of L2 to accumulate in
ND10 and to reorganize these sites, i.e., Sp100 loss and
Daxx attraction, resides within this C-terminal L2 domain.
Discussion
Papillomavirus-encoded L2 proteins translocate into the
nucleus independently of additional PV-encoded proteins
(Florin et al., 2002a). The HPV6b L2 has been shown to
contain three potential NLS, localized at the N-terminus, the
C-terminus, and around amino acid position 286 to 306,
respectively (Sun et al., 1995). Using deletion mutagenesis,
we have identified two potential NLS within the HPV33 L2
protein. An N-terminal stretch of basic amino acids, homol-
ogous to HPV6B L2, does not function as NLS in the
context of HPV33 L2 or when fused to GFP (data not
shown). The characteristics of the L2 NLS are different
from the classical, SV40 T-antigen type of NLS, as the
C-terminal signal is rich in arginine and the central NLS
seems to be bipartite (Fig. 1). It is likely that only one signal
is utilized in vivo.
The HPV L2 protein was the first viral structural protein
shown to accumulate in ND10 and, in addition, to reorga-
nize these nuclear domains (Day et al., 1998; Florin et al.,
2002b). We have now for the first time mapped a short
continuous peptide responsible for directing a viral protein
into ND10 and for the reorganization of this sub-nuclear
structure. Previous analyses for viral proteins attracted into
ND10, e.g. HCMV IE1, have revealed that ND10 localiza-
tion cannot be confined to one distinct region, but rather
requires several functional domains (Ahn et al., 1998;
Wilkinson et al., 1998). The HPV33 L2 core sequence
essential for ND10 homing comprises residues 390–420.
Additional sequences at either side may be required in
addition, since GFP-L2-390/420 did not accumulate in
ND10, in contrast to GFP-L2-360/420 and -390/467. The
adjacent amino acids may influence the folding and/or sta-
bility of the NDLD without directly contributing to the
interaction interface. The core sequence of the HPV33 L2-
NDLD is rich in proline and contains two PXXP-motives as
characteristic feature. Such clusters form PPII-helices (Kay
et al., 2000), which are involved in protein/protein interac-
tion. Even though the amino acid sequence of the NDLD is
rather diverse among papillomaviruses, prolines are con-
served and PXXP-motives are present in most HPV types
sequenced. The conservation of this protein interaction mo-
tif within the NDLD indeed suggests that it serves an im-
portant function.
The L2-induced Daxx attraction also resides within the
NDLD. Since both proteins enrich concomitantly, the
Daxx/L2 interaction may be the driving force for L2 accu-
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Fig. 2. Identification of domains determining L2 subcellular localization.
(A and B) Indicated L2 mutants were expressed in HuTK cells using
recombinant vaccinia viruses. L2 protein was detected 10 h (wtL2, L2-
150/467, -360/467, -1/456, -1/420, -12/390, -1/360, -130) and 6 h (L2-1/
300) postinfection using mAb L2-1 and polyclonal antiserum K233 (L2-
360/467). Costaining with PML is shown by confocal microscopy using a
Zeiss 510 laserscan microscope (B). (C) Expression vectors carrying the
indicated GFP-L2 fusions were transfected into COS-7 cells by electropo-
ration. GFP fluorescence was monitored 48 h later. Arrows indicate
GFP-L2 fusions localizing to nuclear domains 10.
Fig. 3. L2-induced loss of Sp100 requires ND10 localization. Indicated L2
variants were expressed in HuTK cells using recombinant vaccinia vi-
ruses. 12 h postinfection, L2 and Sp100 were detected by immunofluores-
cence. Control: uninfected HuTK cells stained for Sp100.
Fig. 4. L2-induced accumulation of Daxx requires an intact NDLD. Indi-
cated L2 variants were expressed in HuTK cells using recombinant vac-
cinia viruses. (A) L2 and Daxx were detected by immunofluorescence 24 h
postinfection. Control: uninfected HuTK cells stained for Daxx. (B)
Whole cell extracts were prepared and subjected to immunoprecipitation
using mAb 33L2-1. Aliquots of the lysates and the immunoprecipitates
were analyzed by Western blot for L2 and Daxx. Masses of molecular
weight markers are given in kilodalton.
mulation in ND10. Daxx is enriched in ND10 in the absence
of L2. It is therefore conceivable that the ND10-associated
Daxx serves as nucleus for L2 accumulation in ND10. This
can be achieved by direct interaction with Daxx but we
cannot exclude the involvement of additional factors. Al-
ternatively, L2 and Daxx may form a complex in the nu-
cleoplasm, resulting in the accumulation of the complex in
ND10. The latter seems to be more likely, since Daxx/L2
aggregates form independently of PML, e.g. in PML-nega-
tive cells (Becker et al., unpublished observations). In any
case, the formation of these large aggregates requires mul-
tiple interaction domains within both proteins. Daxx has
already been reported to contain at least two independent
protein interaction domains (Hofmann et al., 2002; Ishov et
al., 2002). The L2-NDLD also contains clusters of protein/
protein interaction motives as mentioned above.
The L2-NDLD is also essential to induce the removal of
Sp100 from ND10. As shown previously, the removal of
Sp100 from ND10 is not controlled at the transcriptional
level (Florin et al., 2002b). Our data suggest that L2 protein
needs to be localized at ND10 in order to affect Sp100.
Since the NDLD sequence overlaps with the Sp100 effector
domain, ND10 homing of L2 itself may be sufficient for
inducing the loss of Sp100. Additional functional L2 do-
mains are probably not required. Sp100 is one of the main
structural components of ND10 (Sternsdorf et al., 1997) and
it is conceivable that L2 replaces Sp100 in this nuclear
assembly. L2-induced recruitment of additional factors
driving this process cannot, however, be excluded.
We have previously shown that L2-induced attraction of
L1 into ND10 occurs only after ND10 reorganization, re-
sulting in a delayed accumulation of L1 (Florin et al.,
2002a). Using E. coli-expressed L1 and L2, Finnen and
coworkers recently identified a L2 peptide interacting with
L1, which largely overlaps with the herein described NDLD
(Finnen et al., 2003). Highly likely, virions do not contain
significant amounts of cellular proteins but histones. There-
fore, the interaction of L2 with ND10 components has to be
reversed for those L2 molecules, which incorporate into
virions. It is tempting to speculate that the overlap of protein
interaction domains within the L2-NDLD allows L1 to
replace ND10 components, initiating the viral assembly,
ensuring a timely coordinated morphogenesis, and finally
the release of the virion from ND10.
Taken together, the HPV33 L2-NDLD seems to com-
prise multiple functions, including homing to ND10, bind-
ing of Daxx, dispersal of Sp100, and also attraction of L1
into these nuclear sub-structures (Becker et al., unpublished
observations). These observations support the notion that
L2 serves important nonstructural functions during virus
morphogenesis. Since L2 is also essential for the infection
process (Kawana et al., 2001; Roden et al., 2001; Unckell et
al., 1997), one cannot imagine a complete papillomavirus
life cycle in the absence of L2.
Materials and methods
Mutagenesis and generation of recombinant vaccinia
viruses
C-terminal deletion mutants of HPV33 L2 were obtained by
polymerase chain reaction (PCR) using pCMV33L2 as tem-
plate and oligonucleotide 5-GGTGAATTCCATGAGAC-
ACAAACGATCTAC-3 (ON-33L2-1-5) as forward primer.







CAGTATGTCTACG-3 (ON-33L2-300S-3). N-terminal de-
letion mutants were generated by PCR using oligonucleotide
5-GCGGGATCCCTAGGCCGCCACACGGACA-TC-3
(ON-33L2-467S-3) as reverse primer and oligonucleotides
5-GGTGAATTCCATGGCATCTGCAACACAACT-3
(ON-33L2-M12-5), 5-ATTGAATTCCATGTCATCTAT-
TCAAACTAT-3 (ON-33L2-M150-5), and 5-ATTGAAT-
TCATGGATGGTTTGTATGATGTTTATGC-3 (ON-33L2-
M360-5) as forward primer. L2-12/390 was constructed
by PCR using ON-33L2-M12-5 as forward primer and
5-GGTGAATTCCATGGCATCTGCAAC-ACAACT-3
(ON-33L2-390S-3) as reverse primer. Upstream of the
ATG and downstream of the stop codon recognition sites
for EcoRI and BamHI, respectively, had been added (high-
lighted in boldface). The resulting fragments were cloned
into pCR2.1topo (Invitrogen). Fragments were cut out using
EcoRI and BamHI and cloned into pTM1 cut correspond-
ingly to obtain pTM33L2-1/456, -1/420, -1/360, -1/330,
-1/300, -12/467, -91/467, -150/467, -360/467, and -12/390.
The numbers indicate the 33L2 amino acids still present in
the construct. Corresponding recombinant vaccinia viruses
were obtained after cotransfection with wild-type vaccinia
virus DNA following published procedures (Unckell et al.,
1997). The construction of vac33L1 and vac33L2 has been
described (Unckell et al., 1997). The helper virus VTF7-3,
recombinant for the T7 RNA polymerase, was a generous
gift by Bernhard Moss (Moss et al., 1990).
Generation of GFP-L2 fusions
Fragments of L2 were generated by PCR using ON-
33L2-M360-5 as forward primer and ON-33L2-467S-3
and ON-33L2-420S-3, as reverse primers, cut with EcoR1
and BamH1 and cloned into correspondingly cut pEGFP-C2
(Clontech) to obtain pGFP-33L2-360/467 and -360/420,
respectively. Expression plasmids pGFP-33L2-390/467 and
-390/420 were constructed similarly using ON-33L2-
M390-5 (5-TCTGAATTCAATGAGCAATGTGTCTAT-
ACCT-3) as forward primer, ON-33L2-467S-3 and ON-
33L2-420S-3 as reverse primers, and pEGFP-C1 (Clontech).
165K.A. Becker et al. / Virology 314 (2003) 161–167
Cell lines and antibodies
The osteosarcoma cell line HuTK143 B was obtained
from Bernhard Moss (Moss et al., 1990). All cells were
grown in Dulbecco’s modified Eagle medium supplemented
with 10% fetal calf serum and antibiotics at 37°C. L1- and
L2-specific mouse monoclonal and rabbit polyclonal anti-
bodies have been described (Sapp et al., 1994; Volpers et
al., 1993, 1995). Daxx-specific antibody was purchased
from Santa Cruz. PML- and Sp100-specific rabbit poly-
clonal antiserum was obtained from Chemicon.
Infection of cells
Confluent cells were split 1:4 and grown for 24 h at 37°C
in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal calf serum and antibiotics (Life
Technologies). Cells were washed once with phosphate
buffered saline (PBS), pH 7.3, and subsequently infected
with recombinant vaccinia viruses diluted in serum-free
DMEM at a multiplicity of infection of 2 for each virus.
After incubation for 1 h at room temperature, virus-contain-
ing medium was replaced by supplemented DMEM. Cells
were processed for Western blotting, immunoprecipitation,
and immunofluorescence after the indicated periods of time
at 37°C, respectively.
Immunofluorescence
Cells, grown on coverslips and infected with vaccinia
viruses as described above, were fixated with methanol—
0.02 M EGTA (20°C) for at least 20 min, washed twice
with PBS, and blocked in 5% goat serum dissolved in PBS.
Coverslips were then incubated for 1 h at 37°C with the
indicated antibodies. After extensive washing with PBS,
coverslips were again blocked for 30 min with 5% goat
serum and subsequently incubated at 37°C with Cy3-con-
jugated Affinipure goat anti-rabbit IgG and Cy2-conjugated
Affinipure goat anti-mouse IgG (Jackson Immunoresearch
Products) for 1 h. Coverslips were subsequently washed
with PBS and mounted onto slides using Fluoprep mounting
medium (bioMe´rieux). Pictures were taken using a ZEISS
Axiovert 200M microscope and a ZEISS Axiocam digital
camera. The Axiovision Software 3.0 was used for merging
pictures.
Immunoprecipitation
5  106 cells, either uninfected or infected for 24 h with
VTF7-3 and the indicated L2-recombinant vaccinia virus,
were harvested, washed once with PBS, and suspended in 1
ml of PBS supplemented with 0.5% Nonidet P40 and a
protease inhibitor cocktail. Cell extracts were prepared by
sonication for 30 seconds at 20% output and 20% interval
using a Branson Sonifier 250. This whole cell-lysate was
added to goat anti-mouse IgG-coated dynabeads (Dynal), to
which monoclonal antibodies (mAb) 33L2-1 and 33L2-2
had previously been coupled. After 4 h at 4°C at constant
agitation the beads were collected and washed four times
with 1 ml each of ice-cold PBS. Bound proteins were eluted
with 1% sodium dodecylsulfate (SDS) at 100°C. Lysates
and immunoprecipitates were subsequently analyzed by
SDS polyacrylamide gel electrophoresis (SDS-PAGE)
(La¨mmli, 1970). Proteins were transferred to nitrocellulose
membrane (Towbin et al., 1979). Daxx and L2 were stained
using Daxx-specific polyclonal antibody and mAb 33L2-1,
respectively, and horse radish peroxidase-coupled second-
ary antibody (Jackson Immunoresearch Products). The sig-
nal was visualized by enhanced chemiluminescence (Am-
ersham Pharmacia).
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